16:13 EDT Galectin Therapeutics (GALT) files $200M mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GALT:
- Galectin Therapeutics (GALT) (GALT) Q4 Earnings Cheat Sheet
- Galectin Therapeutics Adds Neurosurgeon Henry Brem to Board
- Galectin Therapeutics appoints Henry Brem to board of directors
- Compelling Risk‑Reward in Galectin Therapeutics: Belapectin’s Differentiated Profile and Biomarker Data Support Buy Rating
- Galectin Therapeutics Adjusts Key NASH Cirrhosis Trial, Resetting Expectations for GALT